A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma

Clinical trial NCT05481437 · RECRUITING

Trial details

NCT number: NCT05481437
Sponsor: Takeda
Status: RECRUITING
Study type: OBSERVATIONAL

Hodgkin Lymphoma

Start date: 2022-08-01
Primary completion: 2027-07-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.